Pharma Focus Europe
ThermoFisher Scientific - Custom and Bulks

LATEST NEWSRead more...

20

Apr 2024

Cognivia Secures €15.5 Million in Strategic Funding for AI and ML-Driven Drug Development

Cognivia an innovative AI company revolutionizing pharmaceutical and biotech clinical research with cuttingedge AIML algorithms proudly announces a significant investment milestone Vesalius Biocapital

19

Apr 2024

Panasonic and Shinobi Therapeutics Collaborate on Cost-Effective iPS Cell Therapy Manufacturing Technology

Shinobi Therapeutics a biotech firm pioneering a new line of immuneevasive iPS cell therapies has forged a collaboration with Panasonic Holdings Corp and Kyoto Universitys Center for iPS

19

Apr 2024

D2M Biotherapeutics Initiates Phase 1 Study of DM919, a Novel MICA/B Antibody for Advanced Solid Tumors, with First Patient Dosed

DM Biotherapeutics Inc a clinicalstage biotech company announced today that it has initiated dosing the first patient in a phase study of DM DM is a novel monoclonal antibody targeting MICAB

18

Apr 2024

X-Therma Receives FDA Approval for XT-Thrive® Drug Master File

XTherma Inc a pioneering biotechnology firm specializing in regenerative medicine and organ preservation has reached a significant milestone with the Food and Drug Administration accepting its Drug Master File for XTThrive This DMF encompasses the Chemistry

17

Apr 2024

Imugene and Kincell Bio Enter Strategic Partnership for Manufacturing and Process Development

Imugene Ltd and Kincell Bio LLC have announced a strategic partnership focusing on manufacturing and process development The agreement involves Imugene selling its Current Good Manufacturing

16

Apr 2024

PharmAlliance's Acquisition of CHEORS Marks a Strategic Step Forward in Pharmaceutical Expansion

PharmAlliance a prominent pharmaceutical and life sciences services platform is thrilled to announce its latest acquisition of Complete Health Economics Outcomes Research Solutions

press releasesRead more...

Evotec and Variant Bio Enter Strategic Partnership to Discover and Develop Fibrosis Treatments

Evotec SE and Variant Bio Inc today announced a collaboration agreement to identify a bestinclass treatment for diseases caused by fibrosis Fibrosis is characterized by marked and pathogenic buildup

EditCo Bio, Inc. Unveils Novel Knockout CD4+ T-cell Pools to Transform Cancer and Autoimmune Research

EditCo Bio Inc a pioneer at the forefront of genome engineering innovation today announced the launch of its Knockout CD Tcell Pools This latest addition to EditCo Bios product lineup marks a significant leap forward in CRISPRmediated

European Medicines Agency (EMA) Grants Orphan Drug Designation for Moleculin's Treatment of Acute Myeloid Leukemia (AML)

Moleculin Biotech Inc a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting hardtotreat tumors and viruses today

22 - 23

Apr 2024

22 - 24

Apr 2024

23 - 25

Apr 2024

24 - 26

Apr 2024

Lab Indonesia 2024

Jakarta, Indonesia

24 - 26

Apr 2024

25 - 26

Apr 2024
patheon - Mastering API production at every scale
7th Pharma Packaging and Labelling Forum 2024
Sartorius Webinar - Pave Your Weigh to Accurate Analytical Results
EUROPEAN PHARMA OUTSOURCING SUMMIT 2024
patheon - Revolutionizing Pharma

TOP ARTICLES

  • 1

    Optimizing Pharmaceutical Viral Vector Production: Techniques and Challenges

    Kate Williamson

    Kate, Editorial Team at Pharma Focus Europe, leverages her extensive background in pharmaceutical communication to craft insightful and accessible content. With a passion for translating complex pharmaceutical concepts, Kate contributes to the team's mission of delivering up-to-date and impactful information to the global Pharmaceutical community.

     

  • 2

    How Can Smart Packaging Revolutionize Pharma with Track-and-Trace Solutions?

    Kate Williamson

    Kate, Editorial Team at Pharma Focus Europe, leverages her extensive background in pharmaceutical communication to craft insightful and accessible content. With a passion for translating complex pharmaceutical concepts, Kate contributes to the team's mission of delivering up-to-date and impactful information to the global Pharmaceutical community.

     

  • 3

    Breaking Down Barriers: Advancements in Biodegradable Drug Delivery

    Kate Williamson

    Kate, Editorial Team at Pharma Focus Europe, leverages her extensive background in pharmaceutical communication to craft insightful and accessible content. With a passion for translating complex pharmaceutical concepts, Kate contributes to the team's mission of delivering up-to-date and impactful information to the global Pharmaceutical community.

     

  • 4

    Precision Oncology Trials: Navigating the Future of Cancer Care

    Kate Williamson

    Kate, Editorial Team at Pharma Focus Europe, leverages her extensive background in pharmaceutical communication to craft insightful and accessible content. With a passion for translating complex pharmaceutical concepts, Kate contributes to the team's mission of delivering up-to-date and impactful information to the global Pharmaceutical community.

     

  • 5

    Revolutionizing Biomanufacturing: Single-use Systems at the Forefront

    Kate Williamson

    Kate, Editorial Team at Pharma Focus Europe, leverages her extensive background in pharmaceutical communication to craft insightful and accessible content. With a passion for translating complex pharmaceutical concepts, Kate contributes to the team's mission of delivering up-to-date and impactful information to the global Pharmaceutical community.

     

KNOWLEDGE BANK

EDITORIAL SECTION